Key Finding
Acupuncture demonstrates significant therapeutic efficacy in ameliorating post-stroke cognitive impairment through three primary mechanisms: modulating neurovascular unit function, remodeling brain networks and connectivity, and enhancing cerebral energy metabolism.
Researchers reviewed recent scientific evidence on using acupuncture to treat cognitive problems that occur after stroke. More than one-third of stroke survivors experience post-stroke cognitive impairment (PSCI), which affects memory, thinking, and daily functioning. This condition creates significant challenges for patients and caregivers alike.
This comprehensive review examined studies published between January 2020 and September 2025 to understand how acupuncture might help stroke survivors with cognitive difficulties. The research found that acupuncture shows significant promise in improving cognitive function after stroke through several biological mechanisms.
The review identified three main ways acupuncture appears to work. First, it helps improve blood flow to the brain, protects the blood-brain barrier (which keeps harmful substances out of brain tissue), and reduces inflammation in the nervous system. Second, acupuncture appears to help the brain rewire itself by enhancing neuroplasticity—the brain's ability to form new connections and pathways. It also improves how different brain regions communicate with each other. Third, acupuncture seems to boost the brain's energy metabolism by helping mitochondria (the cell's power plants) work better and improving how the brain uses glucose for fuel.
The World Health Organization recognizes acupuncture as a complementary therapy for stroke rehabilitation. For stroke survivors experiencing cognitive difficulties, acupuncture may offer a safe, additional treatment option alongside conventional therapies. This research suggests acupuncture could be integrated into personalized treatment plans for post-stroke cognitive recovery.
If you're considering acupuncture for post-stroke cognitive issues, consult with a licensed acupuncturist experienced in neurological rehabilitation.
This comprehensive review synthesizes evidence from January 2020 through September 2025 examining acupuncture's efficacy in treating post-stroke cognitive impairment (PSCI), which affects over one-third of stroke survivors. The review identifies three primary mechanistic pathways: neurovascular unit modulation (improved cerebral perfusion, blood-brain barrier integrity, and reduced neuroinflammation), brain network remodeling (enhanced neuroplasticity, functional connectivity, and regional excitability), and optimized cerebral energy metabolism (improved mitochondrial function and glucose utilization). Clinical evidence demonstrates significant therapeutic efficacy, though specific effect sizes and sample populations are not detailed in this overview article. The authors emphasize translational barriers and advocate for precision medicine approaches in acupuncture-based cerebrovascular cognitive rehabilitation. Clinical takeaway: Acupuncture represents a WHO-recognized adjunctive therapy with demonstrated neuroprotective mechanisms relevant to PSCI management, warranting integration into multimodal post-stroke rehabilitation protocols for appropriate candidates.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.